SAFE ACCU Sinocare Blood Glucose Test Strips 30-60% HCT Venous Plasma Calibration Sample For Glucometer Sugar Blood Met

SAFE ACCU sannuo Blood Glucose Test Strips

30-60% HCT Venous Plasma Calibration Sample

For Glucometer Sugar Blood Meter


Testing your blood glucose regularly may help you better manage your diabetes.

Blood Glucose Test strip

Specification

FAD-GDH System

Blood sample:fresh capillary whole blood

Calibration sample:venous plasma

Test range:1.1-33.3mmol/L(20-600mg/dL)

Test time:10s

Tiny Blood volume:0.6ul Sample Size

HCT:30-60%

Expiry date:24 months

Conditions: -20 Celsius to 55 Celsius

*No coding

*Virtually pain free glucose testing
*Automatically applying blood sample
*200 sets test results in memory
*Memory with capacity for 200 results
*Automatic Strips Ejections
*0.6 ul blood sample

What is in the box?

Application

The Safe Accu Blood Glucose Monitoring system is intended for use outside the body(in vitro diagnostic use) and should not be used for the diagnosis of or screening of diabetes.

The Safe Accu Blood Glucose Test Strip is intended to be used with the Safe Accu Blood Glucose Meter to quantitatively measure glucose(sugar) in capillary whole blood samples drawn from the fingertips or venous whole blood samples.


Tips

Store test strip vials in a cool, dry place below 30 Celsius or 86 Fahrenheit. Keep away from direct sunlight and heat. Do Not Freeze.
Store test strips in their original vial only. To avoid damage or contamination, do not transfer test strips to any other place.
Do not use test strips from any vial that is damaged or left open to air.
6 months after first opening the vial
Do not use test strips beyond the expiration
Test Strips are for single use only.

ABOUT SINOCARE INC.

Sinocare Devotes To Be The Leading Diabetes Management Expert In China And BGM Expert In The World.

In 2016, the acquisition of Trividia and PTS combines the two leading companies in the US with Sinocare. Together with them, Sinocare will work on improving the quality life of users, providing rapid, accurate, portable and easy to use medical device and information management system for personal and professional users.

1. World NO.6 largest BGMS company.
2. Products sold to 135 countries.
3. Branch offices or subsidiaries in US, India, Hong Kong and Taiwan. More than 2,600 employees globally.

Sinocare is a high-tech enterprise dedicated to the development, production and sales of the rapid detection of chronic diseases in the use of bio sensing technology. Since its inception in 2002, has been adhering to the business purpose “Honor Commitment Dedicate to Healthcare", focus on promoting the development of diabetes health.

Sinocare is a high-tech enterprise dedicated to the development, production and sales of the rapid detection of chronic diseases in the use of bio sensing technology. Since its inception in 2002, has been adhering to the business purpose “Honor Commitment Dedicate to Healthcare", focus on promoting the development of diabetes health.

Sinocare as a national high-tech industrialization demonstration project, has won National Innovation Fund support, and took the lead through the ISO 13485 Quality Management System certification and the CE certification of EU. The SANNUO series blood glucose meter and a test strips, with the characteristics of the "accuracy, simple and economic", recognized by the vast number of consumers, the "Sinocare" trademark was identified as "China well known trademark by State Administration of industry and Commerce of. The products are not only popular in China, but also in the international market. In March 19, 2012, the company listed on the Shenzhen stock exchange gem, as the first Bio sensor stock in China. In 2015， the blood glucose meter in the domestic retail market share reached 51%, becoming the industry leader in blood glucose monitoring products, the same year was elected to the Forbes Asian small and medium companies top 200 list. In 2014 September，Sinocare acquired Beijing Jianheng Diabetes Hospital，to step into health service area. In January of 2016, Sinocare acquired Nipro diagnostic Inc. (now renamed as Trividia Health Inc.), the world's sixth BGM enterprise, and reached the international leading BGM corporation, In July of 2016, completed acquisition of PTS Diagnostics, expand the POCT testing business, to provide a more comprehensive solution for chronic disease prevention.